Loading...

Mandana Khalili, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Phone628-206-4766
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UCSFMentor Development Program Certificate2007Medicine
    UCSFM.A.S2005Clinical Research, Department of Epidemiology and Biostatistics
    UCSFHepatology1999Gastroenterology
    McGill UniversityGastroenterology1997Gastroenterology
    University of OttawaM.D.1992Medicine
    Collapse Awards and Honors
    UCSF2017Harold L. Luft Award, Health Disparity Mentoring Award Nomination
    UCSF2016ZSFG Distinction in Medical Education Award Nomination
    UCSF2015Academic Senate Distinction in Mentoring Award Nomination
    NIH2014Mid-Career Investigator Award in Patient Oriented Research
    UCSF2013Academic Senate Distinction in Mentoring Award Nomination
    UCSF2009UCSF University Community Partnerships Council Service Learning Award
    UCSF2008Longitudinal Clinical Experience Appreciation Certificate
    Schering Oncology2001Recognizing Discovery and Innovation in 2001: Milestones in Hepatitis C, Hepatitis Innovation Award
    Gastroenterology Research Group2000American Digestive Health Foundation, Martin Brotman Training and Transition Award
    Canada1988Natural Sciences and Engineering Research Council Award
    McGill University1986J.W. McConnell Entrance Award

    Collapse Overview 
    Collapse Overview
    POSITIONS:
    Chief of Clinical Hepatology, San Francisco General Hospital
    Co-Director, Clinical and Translational Science Institute (CTSI)-Comprehensive Mentoring Program
    Unit Director, CTSI- Mentor Consultation Services

    RESEARCH PROGRAM:
    My research focuses on natural history of chronic viral hepatitis (hepatitis B and hepatitis C), novel treatments for viral hepatitis, health services/health disparity in viral hepatitis, and evaluation of metabolic abnormalities and pathophysiology of diabetes within the context of hepatitis C and B. My group previously evaluated mechanisms of insulin resistance and secretion in a large cohort of hepatitis C infected patients, and is now examining how HCV affects insulin action among the high risk Latino population. We are studying insulin action over time, with and without HCV treatment, using direct measures of insulin secretion and insulin action. We are also studying the mechanisms of immune response to hepatitis C therapy through the Bay Area Hepatitis C Cooperative Study. Through community and participatory research, we are also evaluating hepatitis B management and liver cancer screening practices in hepatitis B-infected underserved populations including the impact of liver cancer screening on mortality. Our focus on health services research involves evaluation of the impact of educational interventions on patient and provider knowledge, attitudes, and barriers to hepatitis C and hepatitis B care as well as primary care-specialist care coordination and access to care for viral hepatitis. In addition, as one of the clinical research centers for the NIH-funded Hepatitis B Research Network, we are currently working on better understanding the natural history of chronic hepatitis B and the optimal long-term treatment for this disease.

    WEBSITES
    http://ctsi.ucsf.edu/about-us/team/programs/career-development-cd
    http://accelerate.ucsf.edu/training/mdp-people
    http://livercenter.ucsf.edu/members/mkhalili.html
    http://ctsi.ucsf.edu/news/about-ctsi/driving-excellence-mentoring-ucsf

    Collapse Research 
    Collapse Research Activities and Funding
    Mentoring Multidisciplinary Patient-Oriented Research in Liver Disease
    NIH/NIAAA K24AA022523Aug 1, 2013 - Apr 30, 2024
    Role: Principal Investigator
    Hepatitis B Research Network (HBRN): Natural History and Treatment Studies
    NIH/NIDDK U01DK082944Sep 30, 2008 - May 31, 2020
    Role: Co-Principal Investigator
    Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos
    NIH/NIDDK R01DK074673Apr 1, 2008 - Feb 28, 2014
    Role: Principal Investigator
    HCV-induced alterations in glucose metabolism
    NIH/NIDDK R03DK071531Aug 15, 2005 - Jul 31, 2009
    Role: Principal Investigator
    Insulin Resistance in HCV Infection
    NIH/NIDDK K23DK062013Aug 1, 2002 - Jun 30, 2007
    Role: Principal Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000083Oct 1, 1974 - Nov 30, 2007
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Global Health
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Sterling RK, King WC, Wahed AS, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG. Evaluating non-invasive markers to identify advanced fibrosis by liver biopsy in HBV/HIV coinfected adults. Hepatology. 2019 Jun 20. PMID: 31220357.
      View in: PubMed
    2. Di Bisceglie AM, King WC, Lisker-Melman M, Khalili M, Belle SH, Feld JJ, Ghany MG, Janssen HLA, Lau D, Lee WM, Ling SC, Cooper S, Rosenthal P, Schwarz KB, Sterling RK, Teckman JH, Terrault N. Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B. J Viral Hepat. 2019 Jul; 26(7):856-865. PMID: 30974509.
      View in: PubMed
    3. Bzowej NH, Tran TT, Li R, Belle SH, Smith CI, Khalili M, Chung R, Tsai N, Terrault N. Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study. Am J Gastroenterol. 2019 May 01. PMID: 31082876.
      View in: PubMed
    4. Chang KM, Traum D, Park JJ, Ho S, Ojiro K, Wong DK, Wahed AS, Terrault NA, Khalili M, Sterling RK, Janssen HLA, Shuhart MC, Lau DT, Roberts LR, Johnson GS, Kaplan DE, Betts MR, Lee WM, Lok ASF. Distinct phenotype and function of circulating Vd1+ and Vd2+ ?dT-cells in acute and chronic hepatitis B. PLoS Pathog. 2019 Apr; 15(4):e1007715. PMID: 30998783.
      View in: PubMed
    5. McGivern DR, Lin HS, Wang J, Benzine T, Janssen HLA, Khalili M, Lisker-Melman M, Fontana RJ, Belle SH, Fried MW. Prevalence and Impact of Hepatitis E Virus Infection Among Persons With Chronic Hepatitis B Living in the US and Canada. Open Forum Infect Dis. 2019 May; 6(5):ofz175. PMID: 31139669.
      View in: PubMed
    6. Brahmania M, Lombardero M, Hansen BE, Terrault NA, Lok AS, Perrillo RP, Belle SH, Di Bisceglie AM, Feld JJ, Lee WM, Fried MW, Janssen HLA. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection. Clin Gastroenterol Hepatol. 2019 Feb 08. PMID: 30743006.
      View in: PubMed
    7. Brouwer WP, Zhao Q, Hansen BE, Lau D, Khalili M, Terrault NA, Di Bisceglie AM, Perrillo RP, Fried MW, Wong D, Feld JJ, Belle SH, Janssen HLA. Improved Definition of HBV Phenotypes based on Genotype-specific Levels of Hepatitis B s Antigen. Clin Gastroenterol Hepatol. 2019 Jan 07. PMID: 30630104.
      View in: PubMed
    8. Feld JJ, Terrault NA, Lin HS, Belle SH, Chung RT, Tsai N, Khalili M, Perrillo R, Cooper SL, Ghany MG, Janssen HLA, Lok AS. Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection. Hepatology. 2018 Dec 14. PMID: 30549279.
      View in: PubMed
    9. Khalili M, Wong RJ. Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net. Dig Dis Sci. 2018 12; 63(12):3250-3252. PMID: 30311153.
      View in: PubMed
    10. Sterling RK, Wahed AS, King WC, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG. Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study. Am J Gastroenterol. 2018 Nov 08. PMID: 30410040.
      View in: PubMed
    11. Kim NJ, Magee C, Cummings C, Park H, Khalili M. Liver Disease Monitoring Practices After Hepatitis C Cure in the Underserved Population. Hepatol Commun. 2018 Oct; 2(10):1274-1283. PMID: 30288480.
      View in: PubMed
    12. Kim NJ, Locke CJ, Park H, Magee C, Bacchetti P, Khalili M. Race and Hepatitis C Care Continuum in an Underserved Birth Cohort. J Gen Intern Med. 2018 Sep 20. PMID: 30238404.
      View in: PubMed
    13. Lee B, Holt EW, Wong RJ, Sewell JL, Somsouk M, Khalili M, Maher JJ, Tana MM. Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved. Autoimmunity. 2018 Aug; 51(5):258-264. PMID: 29890851.
      View in: PubMed
    14. Beck KR, Kim NJ, Khalili M. Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans. Ann Hepatol. 2018 May-June; 17(3):413-418. PMID: 29735789.
      View in: PubMed
    15. Khalili M, Shuhart MC, Lombardero M, Feld JJ, Kleiner DE, Chung RT, Terrault NA, Lisker-Melman M, Sanyal A, Lok AS. Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B. Diabetes Care. 2018 06; 41(6):1251-1259. PMID: 29599296.
      View in: PubMed
    16. Uribe LA, Bacchetti P, Gelman N, Burchard E, Fitch M, Hellerstein M, Khalili M. Impact of Moderate Alcohol Discontinuation on Insulin Action and Secretion in Latinos With and Without Hepatitis C. Alcohol Clin Exp Res. 2018 Mar; 42(3):492-499. PMID: 29220547.
      View in: PubMed
    17. Wen JW, Kohn MA, Wong R, Somsouk M, Khalili M, Maher J, Tana MM. Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans. Am J Gastroenterol. 2018 Feb; 113(2):243-253. PMID: 29380822.
      View in: PubMed
    18. Méndez-Lagares G, Lu D, Chen C, Terrault N, Segal MR, Khalili M, Monto A, Shen H, Manos MM, Lanier LL, Ryan JC, McCune JM, Hartigan-O'Connor DJ. Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success. J Immunol. 2018 02 01; 200(3):1124-1132. PMID: 29263212.
      View in: PubMed
    19. Mukhtar NA, Kathpalia P, Hilton JF, Lau G, Yu A, Grumbach K, Nguyen TT, Chan D, Khalili M. Provider, Patient, and Practice Factors Shape Hepatitis B Prevention and Management by Primary Care Providers. J Clin Gastroenterol. 2017 Aug; 51(7):626-631. PMID: 27811627.
      View in: PubMed
    20. Lok AS, Ganova-Raeva L, Cloonan Y, Punkova L, Lin HS, Lee WM, Ghany MG. Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment. J Viral Hepat. 2017 11; 24(11):1032-1042. PMID: 28581155.
      View in: PubMed
    21. Bourlière M, Gordon SC, Flamm SL, Cooper CL, Ramji A, Tong M, Ravendhran N, Vierling JM, Tran TT, Pianko S, Bansal MB, de Lédinghen V, Hyland RH, Stamm LM, Dvory-Sobol H, Svarovskaia E, Zhang J, Huang KC, Subramanian GM, Brainard DM, McHutchison JG, Verna EC, Buggisch P, Landis CS, Younes ZH, Curry MP, Strasser SI, Schiff ER, Reddy KR, Manns MP, Kowdley KV, Zeuzem S. Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection. N Engl J Med. 2017 06 01; 376(22):2134-2146. PMID: 28564569.
      View in: PubMed
    22. Di Bisceglie AM, Lombardero M, Teckman J, Roberts L, Janssen HL, Belle SH, Hoofnagle JH. Determination of hepatitis B phenotype using biochemical and serological markers. J Viral Hepat. 2017 04; 24(4):320-329. PMID: 27917600.
      View in: PubMed
    23. Beck KR, Kim N, Khalili M. Sofosbuvir-Containing Regimens for Chronic Hepatitis C Are Successful in the Safety-Net Population: A Real-World Experience. Dig Dis Sci. 2016 12; 61(12):3602-3608. PMID: 27743164.
      View in: PubMed
    24. Burman BE, Bacchetti P, Khalili M. Moderate Alcohol Use and Insulin Action in Chronic Hepatitis C Infection. Dig Dis Sci. 2016 08; 61(8):2417-25. PMID: 27007134.
      View in: PubMed
    25. Trager E, Khalili M, Masson CL, Vittinghoff E, Creasman J, Mangurian C. Hepatitis C Screening Rate Among Underserved Adults With Serious Mental Illness Receiving Care in California Community Mental Health Centers. Am J Public Health. 2016 Apr; 106(4):740-2. PMID: 26890183; PMCID: PMC4816001 [Available on 04/01/17].
    26. Evon DM, Wahed AS, Johnson G, Khalili M, Lisker-Melman M, Fontana RJ, Sarkar S, Reeve BB, Hoofnagle JH. Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN). Dig Dis Sci. 2016 Apr; 61(4):1186-96. PMID: 26831489.
      View in: PubMed
    27. Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, Lau DT, Kim WR, Smith C, Carithers RL, Torrey KW, Keith JW, Levine DL, Traum D, Ho S, Valiga ME, Johnson GS, Doo E, Lok AS, Chang KM. Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B. Gastroenterology. 2016 Mar; 150(3):684-695.e5. PMID: 26684441.
      View in: PubMed
    28. Gonzales CA, Bacchetti P, Khalili M. Impact of gender and menopausal status on metabolic parameters in chronic hepatitis C infection. J Viral Hepat. 2016 Mar; 23(3):232-9. PMID: 26554398; PMCID: PMC4809676 [Available on 03/01/17].
    29. Khalili M, Sanyal A. Is there a relationship between hepatitis B surface antibody status and diabetes? J Diabetes. 2016 Jan; 8(1):36-7. PMID: 26201556.
      View in: PubMed
    30. Khalili M, Lombardero M, Chung RT, Terrault NA, Ghany MG, Kim WR, Lau D, Lisker-Melman M, Sanyal A, Lok AS. Diabetes and prediabetes in patients with hepatitis B residing in North America. Hepatology. 2015 Nov; 62(5):1364-74. PMID: 26390278; PMCID: PMC4762364 [Available on 11/01/16].
    31. Wu AH, Khalili M. The birth and potential death of IL28B genotyping for hepatitis C therapy. Per Med. 2015 Mar; 12(2):55-57. PMID: 29754535.
      View in: PubMed
    32. Schaeffer S, Khalili M. Reasons for HCV non-treatment in underserved African Americans: implications for treatment with new therapeutics. Ann Hepatol. 2015 Mar-Apr; 14(2):234-42. PMID: 25671833; PMCID: PMC4384428.
    33. Mukhtar NA, Toy BC, Burman BE, Yu A, Chen AH, Berman P, Nguyen T, Chan D, Hammer H, McCulloch CE, Khalili M. Assessment of HBV preventive services in a medically underserved Asian and Pacific Islander population using provider and patient data. J Gen Intern Med. 2015 Jan; 30(1):68-74. PMID: 25324148; PMCID: PMC4284271.
    34. Burman BE, Bacchetti P, Ayala CE, Gelman N, Melgar J, Khalili M. Liver inflammation is a risk factor for prediabetes in at-risk latinos with and without hepatitis C infection. Liver Int. 2015 Jan; 35(1):101-7. PMID: 25156890; PMCID: PMC4293255.
    35. Shah SC, Kornak J, Khalili M. Depression is not associated with peripheral insulin resistance in patients with chronic hepatitis C infection. J Viral Hepat. 2015 Mar; 22(3):272-80. PMID: 25196736.
      View in: PubMed
    36. Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, Shuhart MC, Lau DT, Kim WR, Fried MW, Sterling RK, Di Bisceglie AM, Han SH, Ganova-Raeva LM, Chang KM, Lok AS. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clin Gastroenterol Hepatol. 2015 Jan; 13(1):183-92. PMID: 25010003.
      View in: PubMed
    37. Larios SE, Masson CL, Shopshire MS, Hettema J, Jordan AE, McKnight C, Young C, Khalili M, Seewald RM, Min A, Hengl N, Sorensen JL, Des Jarlais DC, Perlman DC. Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis. J Subst Abuse Treat. 2014 Apr; 46(4):528-31. PMID: 24462241; PMCID: PMC4019752.
    38. Burman BE, Mukhtar NA, Toy BC, Nguyen TT, Chen AH, Yu A, Berman P, Hammer H, Chan D, McCulloch CE, Khalili M. Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care. Dig Dis Sci. 2014 Jan; 59(1):46-56. PMID: 24052195; PMCID: PMC3947196.
    39. Masson CL, Delucchi KL, McKnight C, Hettema J, Khalili M, Min A, Jordan AE, Pepper N, Hall J, Hengl NS, Young C, Shopshire MS, Manuel JK, Coffin L, Hammer H, Shapiro B, Seewald RM, Bodenheimer HC, Sorensen JL, Des Jarlais DC, Perlman DC. A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. Am J Public Health. 2013 Oct; 103(10):e81-8. PMID: 23947319; PMCID: PMC3853128.
    40. Khalili M, Stewart S. Hepatocellular screening in hepatitis-B infected Asian Americans. J Viral Hepat. 2013 Jul; 20(7):515-6. PMID: 23730847; PMCID: PMC4384647.
    41. Lubega S, Agbim U, Surjadi M, Mahoney M, Khalili M. Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response. Liver Int. 2013 Aug; 33(7):999-1007. PMID: 23509897; PMCID: PMC3692599.
    42. Mukhtar NA, Bacchetti P, Ayala CE, Melgar J, Christensen S, Maher JJ, Khalili M. Insulin sensitivity and variability in hepatitis C virus infection using direct measurement. Dig Dis Sci. 2013 Apr; 58(4):1141-8. PMID: 23086116; PMCID: PMC3566265.
    43. Feldman MD, Steinauer JE, Khalili M, Huang L, Kahn JS, Lee KA, Creasman J, Brown JS. A mentor development program for clinical translational science faculty leads to sustained, improved confidence in mentoring skills. Clin Transl Sci. 2012 Aug; 5(4):362-7. PMID: 22883616.
      View in: PubMed
    44. Brandman D, Bacchetti P, Ayala CE, Maher JJ, Khalili M. Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action. Diabetes Care. 2012 May; 35(5):1090-4. PMID: 22399695; PMCID: PMC3329815.
    45. Sarkar M, Stewart S, Yu A, Chen MS, Nguyen TT, Khalili M. Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans. J Viral Hepat. 2012 Aug; 19(8):594-600. PMID: 22762144.
      View in: PubMed
    46. Mukhtar NA, Ayala C, Maher JJ, Khalili M. Assessment of factors associated with pre-diabetes in HCV infection including direct and dynamic measurements of insulin action. J Viral Hepat. 2012 Jul; 19(7):480-7. PMID: 22676360; PMCID: PMC3375865.
    47. Melia MT, Muir AJ, McCone J, Shiffman ML, King JW, Herrine SK, Galler GW, Bloomer JR, Nunes FA, Brown KA, Mullen KD, Ravendhran N, Ghalib RH, Boparai N, Jiang R, Noviello S, Brass CA, Albrecht JK, McHutchison JG, Sulkowski MS. Racial differences in hepatitis C treatment eligibility. Hepatology. 2011 Jul; 54(1):70-8. PMID: 21488082.
      View in: PubMed
    48. Khalili M, Guy J, Yu A, Li A, Diamond-Smith N, Stewart S, Chen M, Nguyen T. Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers. Dig Dis Sci. 2011 May; 56(5):1516-23. PMID: 21046247; PMCID: PMC3082048.
    49. Surjadi M, Torruellas C, Ayala C, Yee HF, Khalili M. Formal patient education improves patient knowledge of hepatitis C in vulnerable populations. Dig Dis Sci. 2011 Jan; 56(1):213-9. PMID: 20972850; PMCID: PMC3008930.
    50. Sulkowski MS, Shiffman ML, Afdhal NH, Reddy KR, McCone J, Lee WM, Herrine SK, Harrison SA, Poordad FF, Koury K, Deng W, Noviello S, Pedicone LD, Brass CA, Albrecht JK, McHutchison JG. Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate. Gastroenterology. 2010 Nov; 139(5):1602-11, 1611.e1. PMID: 20723545.
      View in: PubMed
    51. Lam KD, Bacchetti P, Abbasi F, Ayala CE, Loeb SM, Shah V, Wen MJ, Reaven GM, Maher JJ, Khalili M. Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity. Hepatology. 2010 Jul; 52(1):38-46. PMID: 20578127; PMCID: PMC4391817.
    52. Terrault N, Khalili M. A glimpse of future hepatitis C virus treatment paradigms. Hepatology. 2010 Feb; 51(2):707-10. PMID: 20104511.
      View in: PubMed
    53. McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, Noviello S, Pedicone LD, Brass CA, Albrecht JK, Sulkowski MS. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. N Engl J Med. 2009 Aug 06; 361(6):580-93. PMID: 19625712.
      View in: PubMed
    54. Kuo A, Tan V, Lan B, Khalili M, Feng S, Roberts JP, Terrault NA. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection. Liver Transpl. 2008 Oct; 14(10):1491-7. PMID: 18825708.
      View in: PubMed
    55. Khalili M.Coinfection with Hepatitis Viruses and HIV Update. In: Peiperl L, Volberding PA, eds. HIV InSite Knowledge Base [textbook on-line]. 2006.
    56. Khalili M, Vardanian AJ, Hamerski CM, Wang R, Bacchetti P, Roberts JP, Terrault NA. Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years. Clin Transplant. 2006 Jan-Feb; 20(1):1-9. PMID: 16556146.
      View in: PubMed
    57. Khalili M, Bernstein D, Lentz E, Barylski C, Hoffman-Terry M. Pegylated interferon alpha-2a with or without ribavirin in HCV/HIV coinfection: partially blinded, randomized multicenter trial. Dig Dis Sci. 2005 Jun; 50(6):1148-55. PMID: 15986873.
      View in: PubMed
    58. Shergill AK, Khalili M, Straley S, Bollinger K, Roberts JP, Ascher NA, Terrault NA. Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am J Transplant. 2005 Jan; 5(1):118-24. PMID: 15636619.
      View in: PubMed
    59. Beatty G, Chu J, Kulkarni K, Lipshutz G, Khalili M, Abbasi F, Stansell J, Reaven GM. Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patients. HIV Clin Trials. 2004 Nov-Dec; 5(6):383-91. PMID: 15682351.
      View in: PubMed
    60. Khalili M, Proietti N. Treatment of the hepatitis C virus in patients coinfected with HIV. Gastroenterol Clin North Am. 2004 Sep; 33(3):479-96, vii-viii. PMID: 15324939.
      View in: PubMed
    61. Sulkowski MS, Felizarta F, Smith C, Slim J, Berggren R, Goodman R, Ball L, Khalili M, Dieterich DT. Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial. J Acquir Immune Defic Syndr. 2004 Apr 15; 35(5):464-72. PMID: 15021311.
      View in: PubMed
    62. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl. 2004 Mar; 10(3):349-55. PMID: 15004760.
      View in: PubMed
    63. Chu JW, Abbasi F, Beatty GW, Khalili M, Koch J, Rosen A, Schmidt JM, Stansell JD, Reaven GM. Methods for quantifying insulin resistance in human immunodeficiency virus-positive patients. Metabolism. 2003 Jul; 52(7):858-61. PMID: 12870161.
      View in: PubMed
    64. Beatty G, Khalili M, Abbasi F, Chu J, Reaven GM, Rosen A, Schmidt JM, Stansell J, Koch J. Quantification of insulin-mediated glucose disposal in HIV-infected individuals: comparison of patients treated and untreated with protease inhibitors. J Acquir Immune Defic Syndr. 2003 May 01; 33(1):34-40. PMID: 12792353.
      View in: PubMed
    65. Khalili M.Peiperl L, Volberding PA, eds. HIV InSite Knowledge Base [textbook on-line]. Coinfection with Hepatitis Viruses and HIV Update. 2003; Available from: HIV InSite.
    66. Khalili M, Behm BW. Hepatitis C in the setting of HIV co-infection. Microbes Infect. 2002 Oct; 4(12):1247-51. PMID: 12467766.
      View in: PubMed
    67. Khalili M, Denham C, Perrillo R. Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C. Am J Gastroenterol. 2000 May; 95(5):1284-9. PMID: 10811340.
      View in: PubMed
    68. Khalili M, Perrillo RP.Clinics in Liver Disease. Interferon Therapy of Hepatitis B. 1999; 3(2):363-87.
    69. Walley VM, Keon CA, Khalili M, Moher D, Campagna M, Keon WJ. Ionescu-Shiley valve failure. II: Experience with 25 low-profile explants. Ann Thorac Surg. 1992 Jul; 54(1):117-22; discussion 122-3. PMID: 1610222.
      View in: PubMed
    70. Walley VM, Keon CA, Khalili M, Moher D, Campagna M, Keon WJ. Ionescu-Shiley valve failure. I: Experience with 125 standard-profile explants. Ann Thorac Surg. 1992 Jul; 54(1):111-6. PMID: 1610221.
      View in: PubMed
    71. Wolfsohn AL, Walley VM, Davies RA, Keon CA, Khalili M, Keon WJ. The University of Ottawa Heart Institute Cardiac Transplant Program: the first 100 transplants. A pathologic study of the explanted hearts. Mod Pathol. 1992 Mar; 5(2):158-64. PMID: 1574494.
      View in: PubMed